Jay Galeota was the President and Chief Executive Officer of Inheris BioPharma, Inc. until May, 2020. Prior to that, Jay was President and Chief Operating Officer of G&W Laboratories, Inc. and Chief Strategy & Business Development Officer and President, Emerging Business at Merck & Co., Inc. He is a 31-year industry veteran and spent 28 years at Merck, where he served in many diverse positions across commercial operations, business development, strategy, and innovation, both globally and in the U.S. Jay is known for his passion for innovation and development of break-through products and business opportunities. Jay holds a Bachelor of Science degree in biology from Villanova University and is a graduate of Harvard Business School’s Advanced Management Program. He served as an Independent Director at Melinta Therapeutics, Inc. (MLNT) and Assertio Therapeutics, Inc. (ASRT), and is on the boards of Hackensack Meridian Health System, Harvard Business School’s Healthcare Alumni Association, the New Jersey Symphony Orchestra, and the Metuchen Edison Woodbridge YMCA. Jay is also a member of Villanova University’s Deans Advisory Council. In addition, Jay currently serves as the Honorary Commander of the United States Air Force 113th Wing, DCANG, Joint Base Andrews and has been a guest lecturer at the Wharton School of the University of Pennsylvania. Jay is also the co-author of several publications in Harvard Business Review and Chief Executive. Jay currently resides in New Jersey with his wife and three children. In addition to business, his interests include sailing, skiing, flying, automobiles and music.